Work

Supplementary Figure Legend from A Potent Combination of the Novel PI3K Inhibitor, GDC-0941, with Imatinib in Gastrointestinal Stromal Tumor Xenografts: Long-Lasting Responses after Treatment Withdrawal

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 240K

DOI: 10.1158/1078-0432.22450700

Authors: Giuseppe Floris, Agnieszka Wozniak, Raf Sciot, Haifu Li, Lori Friedman, Thomas Van Looy, Jasmien Wellens, Peter Vermaelen, Christophe M. Deroose, Jonathan A. Fletcher, Maria Debiec-Rychter, Patrick Schöffski

Institutions: Genentech, Brigham and Women's Hospital, KU Leuven, Universitair Ziekenhuis Leuven

Language: English

Topic: Gastrointestinal Tumor Research and Treatment

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Funders: Fonds Wetenschappelijk Onderzoek, National Institutes of Health, Genentech

OpenAlex ID: W4361908165

Cites: 25

Cited by:

Related to: 10